Lipid-lowering drugs for primary prevention are associated with a significant survival benefit, but use has decreased over time, according to a study published online Nov. 16 in Circulation.
Dec 4, 2023
0
16
Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified the first blood biomarker for myocarditis, a cardiac disease that is often misdiagnosed as myocardial infarction. Nevertheless, ...
May 26, 2021
0
5
New analysis of Medicare's Hospital Compare portal shows the statistical methodology used to rate and compare hospitals underestimates mortality rates of acute myocardial infarction (AMI) at small hospitals. The research, ...
Apr 19, 2017
0
0
Typical methods of drug delivery to the heart require surgical procedures involving incisions in the chest wall and bones. To efficiently treat cardiovascular and related vascular diseases without surgery, a KAIST research ...
Sep 18, 2018
0
24
Patients who have received at least one COVID-19 vaccine dose after acute coronary syndromes do not have a reduced risk for cardiovascular events, according to a research letter published online May 30 in JAMA Network Open.
Jun 3, 2024
0
4
Levels of antiphospholipid antibodies, which are associated with rheumatic diseases, are also elevated in myocardial infarction without any autoimmune co-morbidity, a study from Karolinska Institutet in Sweden published in ...
Oct 23, 2018
0
32
A heart attack, or myocardial infarction, is one of the leading causes of mortality worldwide, resulting in 18 million deaths per year. These numbers are expected to increase in coming years because of cardiovascular complications ...
Aug 30, 2022
0
6
A variant typical of the Finnish population that protects against heart diseases was identified in the FinnGen genomic study coordinated by the University of Helsinki. The risk of developing heart diseases is roughly one-fifth ...
Aug 17, 2022
0
44
A drug used to treat multiple sclerosis may also be effective at preventing and reversing the leading cause of heart attack, a new study has found.
Jan 30, 2012
0
0
A randomized comparison of a dual therapy stent – which combines low-dose sirolimus delivery from an abluminal biodegradable polymer matrix with a covalently bound anti-CD34 antibody layer – with a paclitaxel-eluting ...
Nov 11, 2011
0
0
